lestaurtinib (CEP-701) - Teva, Kyowa Hakko Kirin
ibrutinib - Generic mfg.
Xospata (gilteritinib) - Astellas
rebastinib (DCC-2036) - Deciphera
dubermatinib (TP-0903) - Sumitomo Dainippon
Vanflyta (quizartinib) - Daiichi Sankyo
Iclusig (ponatinib) - Takeda, Otsuka, Incyte
Nexavar (sorafenib) - Bayer, Amgen
FF-10101 - Fujifilm Holdings
KW-2449 - Kyowa Hakko Kirin
Rydapt (midostaurin) - Novartis
dovitinib (TKI258) - Allarity Therap
nintedanib - Generic mfg.
tandutinib (MLN518) - Takeda
IACS-010759 - UT MD Anderson Cancer Center
Sutent (sunitinib) - Pfizer
crenolanib besylate (ARO-002) - AROG
https://ash.confex.com/ash/2020/webprogram/Paper141986.html
 
Xiyuan Lu1; Alessia Lodi, PhD2; Lina Han, PhD3; Joseph R Marszalek, PhD4; Marina Konopleva, MD, PhD5; Stefano Tiziani, PhD2
 
Nov 5, 2020
 
Prev Next